Urban eye allergy syndrome: A new clinical entity?

Current Medical Research and Opinion

Volumn 24, Issue 8, 2008, Pages 2295-2302

  Leonardi, Andrea ^a   Lanier, Bob ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b North Texas Institute for Clinical Trials   (United States)

Author keywords

Idiopathic conjunctivitis; Nonspecific mucosal inflammation; Pollution; Red eye; Urban eye allergy syndrome; Vasomotor

Indexed keywords

ALLERGEN; ANTIOXIDANT; ARTIFICIAL TEAR; AZELASTINE; EPINASTINE; KETOTIFEN; NONSTEROID ANTIINFLAMMATORY AGENT; OLOPATADINE;

AIR POLLUTANT; AIR POLLUTION; ARTICLE; CONJUNCTIVITIS; DRUG RESPONSE; EYE ALLERGY; HUMAN; INCIDENCE; PATHOGENESIS; POLLEN; PREVALENCE; URBAN AREA; URBAN EYE ALLERGY SYNDROME; URBAN POPULATION;

AIR POLLUTANTS; ALLERGENS; CONJUNCTIVITIS, ALLERGIC; HUMANS; URBAN POPULATION;

EID: 50149092858     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/03007990802222774     Document Type: Article

References (39)

1. Seltzer JM. Building-related illnesses. J Allergy Clin Immunol 1994;94:351-61
2. Heinrich J, Wichmann HE. Traffic related pollutants in Europe and their effect on allergic disease. Curr Opin Allergy Clin Immunol 2004;4:341-8
3. Bernstein JA, Alexis N, Barnes C, et al. Health effects of air pollution. J Allergy Clin Immunol 2004;114:1116-23
4. Riediker M, Monn C, Koller T, et al. Air pollutants enhance rhinoconjuctivitis symptoms in pollen-allergic individuals. Ann Allergy Asthma Immunol 2001;87:311-8
5. Knox RB, Suphioglu C, Taylor P, et al. Major grass pollen allergen Lol p 1 binds to diesel exhaust particles: implications for asthma and air pollution. Clin Exp Allergy 1997;27:246-51
6. Majd A, Kaibi S. The effect of Theran's polluted atmosphere on ultrastructural changes and allergenicity of Cupressus arizonica pollen grains. J Aerobiol 1997;13:407-17
7. Majd A, Chehregani A, Moin M, et al. The effects of air pollution on structures, proteins and allergenicity of pollen grains. Aerobiologia 2004;20:111-8
8. Behrendt H, Becker WM, Fritzsche C, et al. Air pollution and allergy: experimental studies on modulation of allergen release from pollen by air pollutants. Int Arch Allergy Immunol 1997;113:69-74
9. Bagarozzi Jr DA, Travis J. Ragweed pollen proteolytic enzymes: possible roles in allergies and asthma. Phytochemistry 1998; 47:593-8
10. Hitzfeld B, Friedrichs KH, Ring J, et al. Airborne particulate matter modulates the production of reactive oxygen species in human polymorphonuclear granulocytes. Toxicology 1997; 120:185-95
11. Basci A, Dharajiya N, Choudhury BK, et al. Effect of pollen-mediated oxidative stress on immediate hypersensitivity reactions and late-phase inflammation in allergic conjunctivitis. J Allergy Clin Immunol 2005;116:836-43
12. Bourcier T, Viboud C, Cohen JC, et al. Effects of air pollution and climatic conditions on the frequency of ophthalmological emergency examinations. Br J Ophthalmol 2003;87:809-11
13. Spix C, Anderson HR, Schwartz J, et al. Short-term effects of air pollution on hospital admissions of respiratory diseases in Europe: a quantitative summary of APHEA study results. Air pollution and health: a European approach. Arch Environ Health 1998;53:54-64
14. Hajat S, Haines A, Atkinson RW, et al. Association between air pollution and daily consultations with general practitioners for allergic rhinitis in London, United Kingdom. Am J Epidemiol 2001;153:704-14
15. Krämer U, Koch T, Ranft U, et al. Traffic-related air pollution is associated with atopy in children living in urban areas. Epidemiology 2000;11:64-70
16. Versura P, Profazio V, Cellini M, et al. Eye discomfort and air pollution. Ophthalmologica 1999;213:103-9
17. Novaes P, do Nascimento Saldiva PH, Kara-Jose N, et al. Ambient levels of air pollution induce goblet-cell hyperplasia in human conjunctival epithelium. Environ Health Perspect 2007;115:1752-6
18. Santo RM, Kara-Jose N, Novaes P, et al. Effects of São Paulo air pollution on the mice conjuctiva. ARVO 2007 e-abstract [www.arvo.org]
19. Hempel-Jørgensen A, Kjaergaard SK, Molhave L. Cytological changes and conjunctival hyperemia in relation to sensory eye irritation. Int Arch Occup Environ Health 1998;71:225-35
20. Enberg RN. Perennial nonallergic rhinitis: a retrospective review. Ann Allergy 1989;63:513-6
21. Bielory L. Vasomotor (perennial chronic) conjunctivitis. Curr Opin Allergy Clin Immunol 2006;6:355-60
22. Dottorini ML, Bruni B, Peccini F, et al. Skin prick-test reactivity to allergens and allergic symptoms in an urban population of central Italy: a longitudinal study. Clin Exp Allergy 2007; 37:188-96
23. Baudouin C, Bourcier T, Brignole F, et al. Correlation between tear IgE levels and HLA-DR expression by conjunctival cells in allergic and nonallergic chronic conjunctivitis. Graefes Arch Clin Exp Ophthalmol 2000;238:900-4
24. Burr ML, Emberlin JC, Treu R, et al. Pollen counts in relation to the prevalence of allergic rhinoconjunctivitis, asthma and atopic eczema in the International Study of Asthma and Allergies in Childhood (ISAAC). Clin Exp Allergy 2003; 33:1675-80
25. Saxon A, Diaz-Sanchez D. Air pollution and allergy: you are what you breathe. Nat Immunol 2005;6:223-6
26. Gukasyan HJ, Kim KJ, Lee VH, et al. Glutathione and its transporters in ocular surface defense. Ocul Surf 2007;5:269-79
27. Diaz-Sanchez D, Garcia MP, Wang M, et al. Nasal challenge with diesel exhaust particles can induce sensitization to a neoallergen in the human mucosa. J Allergy Clin Immunol 1999;104:1183-8
28. London SJ, Daly AK, Cooper J, et al. Polymorphism of glutathione S-transferase M1 and lung cancer risk among African-Americans and Caucasians in Los Angeles County, California. J Natl Cancer Inst 1995;87:1246-53
29. Gilliland FD, Li Y-F, Saxon A, et al. Effect of glutathione-S-transferase M1 and P1 genotypes on xenobiotic enhancement of allergic responses: randomised, placebo-controlled crossover study. Lancet 2004;363:119-25
30. Norn M. Pollution keratoconjunctivitis. A review. Acta Ophthalmol (Copenh) 1992;70:269-73
31. Berra A, Sandes E, Hansen L, et al. Effects of air pollution in a human conjunctival epithelial cell line. ARVO 2007 [www.arvo.org]
32. Shore SA, Schwartzman IN, Le Blanc B, et al. Tumor necrosis factor receptor 2 contributes to ozone-induced airway hyperresponsiveness in mice. Am J Respir Crit Care Med 2001; 164:602-7
33. Yang IA, Yang IA, Holz O, et al. Association of tumor necrosis factor-alpha polymorphisms and ozone-induced change in lung function. Am J Respir Crit Care Med 2005; 171:171-6
34. Leonardi A. In-vivo diagnostic measurements of ocular inflammation. Curr Opin Allergy Clin Immunol 2005;5:464-72
35. Leonardi A. Emerging drugs for ocular allergy. Expert Opin Emerging Drugs 2005;10:505-20
36. Rosenwasser LJ, O'Brien T, Weyne J. Mast cell stabilization and anti-histamine effects of olopatadine ophthalmic solution: a review of pre-clinical and clinical research. Curr Med Res Opin 2005;21:1377-87
37. Brockman HL, Momsen MM, Knudtson JR, et al. Interactions of olopatadine and selected antihistamines with model and natural membranes. Ocul Immunol Inflamm 2003;11:247-68
38. Leonardi A, Abelson MB. Double-masked, randomized, placebo-controlled clinical study of the mast cell-stabilizing effects of treatment with olopatadine in the conjunctival allergen challenge model in humans. Clin Ther 2003;25: 2539-52
39. Cook EB, Stahl JL, Barney NP, et al. Olopatadine inhibits anti-immunoglobulin E-stimulated conjunctival mast cell upregulation of ICAM-1 expression on conjunctival epithelial cells. Ann Allergy Asthma Immunol 2001;87:424-9